» Articles » PMID: 37268972

Effectiveness of Smoking Cessation on the High-risk Population of Lung Cancer with Early Screening: a Systematic Review and Meta-analysis of Randomized Controlled Trials Until January 2022

Overview
Publisher Biomed Central
Date 2023 Jun 2
PMID 37268972
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lung cancer has always been the malignant tumor with the highest incidence rate. Smoking is the most important risk factor for lung cancer. Although potential positive effects of smoking cessation interventions on the high-risk population of lung cancer have been observed, evidence of its definitive effect remains uncertain. This study aimed to summarize the evidence related to the effects and safety of smoking cessation interventions for the high-risk population of lung cancer.

Methods: A systematic literature search was conducted through the following seven databases: PubMed, Embase, Web of Science, CENTRAL, CINAHL, PsycINFO, and Science Direct. Screening and assessment for risk of bias were conducted by two independent reviewers. Meta-analysis was performed for the 7-day-point prevalence of smoking abstinence and continuous smoking abstinence using RevMan 5.3 software.

Results: Meta-analysis results show that in the 7-day-point prevalence of smoking abstinence (by patient-reported outcome): individualized intervention was significantly higher than that of the standard care [RR = 1.46, 95%CI = (1.04,2.06), P < 0.05]. Moreover, the smoking cessation interventions were significantly elevated than that of standard care [RR = 1.58, 95%CI = (1.12, 2.23), P < 0.05] within 1-6 month follow-up time. In line with the findings in cigarette smoking, the continuous smoking abstinence of E-cigarettes (biochemical verified): E-cigarettes were significantly higher than that of the standard care [RR = 1.51, 95%CI = (1.03, 2.21), P < 0.05], and within 1-6 month follow-up time, the smoking cessation interventions were significantly greater than that of standard care [RR = 1.51, 95%CI = (1.03, 2.21), P < 0.05]. Publication bias was detected possibly.

Conclusions: The results of this systematic review show that smoking cessation intervention is effective for long-term lung cancer high-risk smokers who participate in early screening, of which E-cigarettes are the best, followed by individual smoking cessation.

Trial Registration: CRD42019147151. Registered 23 June 2022.

Citing Articles

Smoking Avoidance, Physical Activity and Diet as Preventative Behaviours for Lung, Prostate and Colorectal Cancer - A Comparison of the Extended Parallel Process Model Groups.

Domoslawska-Zylinska K, Wlodarczyk D Int J Public Health. 2025; 70:1607278.

PMID: 39968234 PMC: 11832310. DOI: 10.3389/ijph.2025.1607278.


Trends in tracheal, bronchial and lung cancer attributed to smoking in South America: Global Burden of Disease analysis 1990-2019.

Salerno P, Dallan L, Pereira G, Fernandes P, Terra R, Rajagopalan S Rev Panam Salud Publica. 2024; 48:e30.

PMID: 38576842 PMC: 10993800. DOI: 10.26633/RPSP.2024.30.

References
1.
Taylor K, Hagerman C, Luta G, Bellini P, Stanton C, Abrams D . Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial. Lung Cancer. 2017; 108:242-246. PMC: 5476481. DOI: 10.1016/j.lungcan.2017.01.020. View

2.
Cheung K, de Ruijter D, Hiligsmann M, Elfeddali I, Hoving C, Evers S . Exploring consensus on how to measure smoking cessation. A Delphi study. BMC Public Health. 2017; 17(1):890. PMC: 5696733. DOI: 10.1186/s12889-017-4902-7. View

3.
Fucito L, Czabafy S, Hendricks P, Kotsen C, Richardson D, Toll B . Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer. 2016; 122(8):1150-9. PMC: 4828323. DOI: 10.1002/cncr.29926. View

4.
Iaccarino J, Duran C, Slatore C, Wiener R, Kathuria H . Combining smoking cessation interventions with LDCT lung cancer screening: A systematic review. Prev Med. 2019; 121:24-32. DOI: 10.1016/j.ypmed.2019.02.016. View

5.
de Koning H, van der Aalst C, de Jong P, Scholten E, Nackaerts K, Heuvelmans M . Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6):503-513. DOI: 10.1056/NEJMoa1911793. View